News Overview

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 11-Apr-2022 titled Glenmark Specialty S.A. receives approval for conducting Phase 1 Clinical Trial of its Novel Molecule GRC 54276 in patients with Advanced Solid Tumors and Hodgkin???s Lymphoma

Promoter/Promoter Group of T T Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of KPIT Technologies Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Rane Engine Valve Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Healthcare Global Enterprises Limited has informed the Exchange about Corrigendum to Postal Ballot Notice dated April 01, 2022

Promoter/Promoter Group of Aarey Drugs & Pharmaceuticals Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Gokul Refoils and Solvent Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of SBI Life Insurance Company Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of Titagarh Wagons Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022

Promoter/Promoter Group of SPL Industries Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022